Stock Earnings

Question 1

What are Chugai Pharmaceutical Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Chugai Pharmaceutical Co Ltd has a total asset of $2,208,373, Net profit of $387,317

Question 2

What are the key financial ratios for CHGCF?

Accepted Answer

Chugai Pharmaceutical Co Ltd's Current ratio is 7.19, has a Net margin is 33.08, sales per share of $711.34.

Question 3

How is Chugai Pharmaceutical Co Ltd's revenue broken down by segment or geography?

Accepted Answer

Currently Chugai Pharmaceutical Co Ltd data is not available.

Question 4

Is Chugai Pharmaceutical Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Chugai Pharmaceutical Co Ltd has a net profit of $387,317

Question 5

Does Chugai Pharmaceutical Co Ltd have any liabilities?

Accepted Answer

yes, Chugai Pharmaceutical Co Ltd has liability of 306,874

Question 6

How many outstanding shares for Chugai Pharmaceutical Co Ltd?

Accepted Answer

Chugai Pharmaceutical Co Ltd has a total outstanding shares of 1,645.52

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,213,713	1,170,611	1,111,367	1,259,726	999,759	786,946
Revenue Growth (YoY)	6%	5%	-12%	26%	27%	15%
Cost of Revenue	370,432	337,854	412,650	476,251	337,680	273,465
Gross Profit	843,281	832,757	698,717	783,475	662,079	513,481
Selling, General & Admin	111,954	109,733	111,916	99,583	100,754	92,992
Research & Development	187,420	176,744	169,061	148,059	131,276	116,601
Operating Expenses	290,054	284,957	253,785	249,525	233,840	211,298
Other Non Operating Income (Expenses)	--	709	407	-2,912	-2,568	-1,467
Pretax Income	553,409	543,034	443,821	531,166	419,385	298,188
Income Tax Expense	156,247	155,717	118,349	156,737	116,390	83,455
Net Income	397,161	387,317	325,472	374,429	302,995	214,733
Net Income Growth	3%	19%	-13%	24%	41%	36%
Shares Outstanding (Diluted)	1,645.7	1,645.63	1,645.49	1,645.33	1,645.22	1,645.08
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	241.34	235.36	197.8	227.57	184.17	130.53
EPS Growth	3%	19%	-13%	24%	41%	36%
Free Cash Flow	--	392,701	335,666	172,873	206,760	143,625
Free Cash Flow Per Share	--	238.63	203.99	105.06	125.67	87.3
Gross Margin	69.47%	71.13%	62.87%	62.19%	66.22%	65.24%
Operating Margin	45.58%	46.79%	40.03%	42.38%	42.83%	38.39%
Profit Margin	32.72%	33.08%	29.28%	29.72%	30.3%	27.28%
Free Cash Flow Margin	--	33.54%	30.2%	13.72%	20.68%	18.25%
EBITDA	--	579,465	476,672	565,384	459,107	332,559
EBITDA Margin	--	49.5%	42.89%	44.88%	45.92%	42.25%
D&A For EBITDA	--	31,665	31,740	31,434	30,868	30,376
EBIT	553,227	547,800	444,932	533,950	428,239	302,183
EBIT Margin	45.58%	46.79%	40.03%	42.38%	42.83%	38.39%
Effective Tax Rate	28.23%	28.67%	26.66%	29.5%	27.75%	27.98%

Chugai Pharmaceutical Co Ltd (CHGCF) Price